O(6)-methylguanine-DNA methyltransferase in equine sarcoids: molecular and epigenetic analysis.
Authors: Altamura Gennaro, Strazzullo Maria, Corteggio Annunziata, Francioso Romina, Roperto Franco, D'Esposito Maurizio, Borzacchiello Giuseppe
Journal: BMC veterinary research
Summary
# Editorial Summary: MGMT Expression and Epigenetic Silencing in Equine Sarcoids Equine sarcoids, induced by cross-species infection with bovine papillomavirus types 1 and 2, represent the most prevalent cutaneous neoplasm in horses yet lack effective therapeutic options—a gap partly attributable to incomplete understanding of the molecular mechanisms driving tumourigenesis. Altamura and colleagues investigated whether O6-methylguanine-DNA methyltransferase (MGMT), a tumour-suppressor protein implicated in cancer development across multiple species, undergoes functional loss in sarcoid lesions through both altered expression and epigenetic silencing. By comparing MGMT protein expression and DNA methylation patterns between normal and sarcoid-affected tissues, the research team sought to elucidate whether DNA methylation of the MGMT gene promoter region accounts for reduced oncosuppressor function in these tumours. The findings demonstrate that epigenetic mechanisms—specifically aberrant DNA methylation—contribute to MGMT downregulation in equine sarcoid cells, suggesting that loss of this key DNA-repair protein may facilitate viral-driven neoplastic transformation. These results have significant implications for practitioners, as they identify a potential molecular target for therapeutic intervention and highlight why sarcoids prove so refractory to conventional treatment, whilst potentially opening avenues for epigenetic-based or DNA-repair–enhancing approaches in future management strategies.
Read the full abstract on PubMed
Practical Takeaways
- •Understanding MGMT's role in sarcoid development may eventually lead to more effective therapeutic targets for this common equine skin tumour
- •Epigenetic mechanisms appear to play a regulatory role in sarcoid formation, suggesting potential for targeted molecular interventions
- •This molecular research provides foundational knowledge for developing improved treatment options beyond current limited therapies
Key Findings
- •MGMT (O6-methylguanine-DNA methyltransferase) expression was assessed in normal versus sarcoid equine cells and tissues
- •DNA methylation profile analysis revealed epigenetic mechanisms regulating MGMT expression in sarcoid development
- •Study identifies MGMT as a putative oncosuppressor gene involved in equine sarcoid tumourigenesis